Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Intellia Therapeutics, Inc. (NTLA)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
1 Mar 2024
BASTA JAMES
EVP, General Counsel, Officer
Intellia Therapeutics, Inc.
(NTLA)
81,571
-2%
2,297
$32.99
$75,778.03
SELL
1 Mar 2024
Clark Eliana
EVP, Chief Technical Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
71,470
-0%
605
$32.99
$19,958.95
SELL
8 Jan 2024
Sepp-Lorenzino Laura
EVP, Chief Scientific Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
44,594
-4%
2,275
$28.87
$65,681.74
SELL
3 Jan 2024
BASTA JAMES
EVP, General Counsel, Officer
Intellia Therapeutics, Inc.
(NTLA)
51,474
-6%
3,805
$29.46
$112,095.30
SELL
3 Jan 2024
Clark Eliana
EVP, Chief Technical Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
45,146
-9%
4,608
$29.50
$135,954.30
SELL
3 Jan 2024
Hicks Derek
EVP, Chief Business Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
36,987
-9%
3,877
$29.46
$114,216.41
SELL
3 Jan 2024
Sepp-Lorenzino Laura
EVP, Chief Scientific Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
46,202
-10%
5,532
$29.46
$162,972.72
SELL
3 Jan 2024
Goddard Glenn
EVP, Chief Financial Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
40,585
-11%
5,365
$29.46
$158,052.89
SELL
3 Jan 2024
LEONARD JOHN M
President and CEO, Director, Officer
Intellia Therapeutics, Inc.
(NTLA)
846,486
-2%
19,223
$29.46
$566,309.56
SELL
3 Jan 2024
Lebwohl David
EVP, Chief Medical Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
54,372
-9%
5,843
$29.46
$172,134.78
SELL
31 Oct 2023
Bhanji Muna
Director
Intellia Therapeutics, Inc.
(NTLA)
11,996
-2%
265
$23.90
$6,333.50
SELL
25 Aug 2023
Thomas R. Carper
Congressman (Senate)
Intellia Therapeutics, Inc.
(NTLA)
N/A
N/A
N/A
$1,001 - $15,000
SELL
31 Jul 2023
Bhanji Muna
Director
Intellia Therapeutics, Inc.
(NTLA)
12,261
-2%
265
$42.33
$11,217.45
SELL
6 Jul 2023
Bhanji Muna
Director
Intellia Therapeutics, Inc.
(NTLA)
12,526
-12%
1,867
$39.30
$73,373.10
SELL
3 Jul 2023
Clark Eliana
EVP, Chief Technical Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
45,146
-0%
360
$40.51
$14,583.60
SELL
20 Jun 2023
Clark Eliana
EVP, Chief Technical Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
45,146
-9%
5,000
$45.00
$225,000.00
BUY
22 May 2023
Thomas R. Carper
Congressman (Senate)
Intellia Therapeutics, Inc.
(NTLA)
N/A
N/A
N/A
$1,001 - $15,000
SELL
1 Mar 2023
BASTA JAMES
EVP, General Counsel, Officer
Intellia Therapeutics, Inc.
(NTLA)
55,279
-1%
1,088
$43.88
$47,741.44
SELL
4 Jan 2023
BASTA JAMES
EVP, General Counsel, Officer
Intellia Therapeutics, Inc.
(NTLA)
19,559
-5%
1,138
$37.21
$42,344.98
SELL
4 Jan 2023
Goddard Glenn
EVP, Chief Financial Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
15,404
-13%
2,427
$37.21
$90,308.66
SELL
4 Jan 2023
Lebwohl David
EVP, Chief Medical Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
25,687
-9%
2,574
$37.21
$95,778.54
SELL
4 Jan 2023
Hicks Derek
EVP, Chief Business Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
17,306
-9%
1,812
$37.21
$67,424.52
SELL
4 Jan 2023
LEONARD JOHN M
President and CEO, Director, Officer
Intellia Therapeutics, Inc.
(NTLA)
766,825
-0%
6,673
$37.21
$248,302.33
SELL
4 Jan 2023
Sepp-Lorenzino Laura
EVP, Chief Scientific Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
18,318
-20%
4,838
$37.82
$182,981.60
SELL
1 Jul 2022
Clark Eliana
EVP, Chief Technical Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
14,473
-12%
2,028
$37.65
$76,356.90
SELL
28 Feb 2022
Donald Sternoff Beyer Jr.
Congressman (House)
Intellia Therapeutics, Inc.
(NTLA)
N/A
N/A
N/A
$15,001 - 50,000
SELL
1 Jan 2022
Lebwohl David
EVP, Chief Medical Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
10,922
-8%
1,051
$112.24
$117,964.23
SELL
1 Jan 2022
Sepp-Lorenzino Laura
EVP, Chief Scientific Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
4,815
-19%
1,148
$112.25
$128,863.00
SELL
1 Jan 2022
Goddard Glenn
EVP, Chief Financial Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
2,049
-33%
1,013
$112.24
$113,699.12
SELL
1 Jan 2022
LEONARD JOHN M
President and CEO, Director, Officer
Intellia Therapeutics, Inc.
(NTLA)
724,660
-0%
2,493
$112.26
$279,851.72
SELL
5 Nov 2021
Lebwohl David
EVP, Chief Medical Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
9,914
-19%
2,400
$132.72
$318,534.62
SELL
29 Oct 2021
Donald Sternoff Beyer Jr
Congressman (House)
Intellia Therapeutics, Inc.
(NTLA)
N/A
N/A
N/A
$1,001 - $15,000
SELL
14 Oct 2021
Lebwohl David
EVP, Chief Medical Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
10,563
-18%
2,400
$128.44
$308,249.12
SELL
11 Oct 2021
Crowley John F
Director
Intellia Therapeutics, Inc.
(NTLA)
2,094
-54%
2,500
$119.55
$298,875.00
SELL
5 Oct 2021
Crowley John F
Director
Intellia Therapeutics, Inc.
(NTLA)
10,814
-48%
10,000
$130.54
$1,305,390.90
SELL
21 Sep 2021
Lebwohl David
EVP, Chief Medical Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
791
-75%
2,400
$149.81
$359,544.00
SELL
20 Sep 2021
Donald Sternoff Beyer Jr
Congressman (House)
Intellia Therapeutics, Inc.
(NTLA)
N/A
N/A
N/A
$1,001 - $15,000
SELL
7 Sep 2021
Goddard Glenn
EVP, Chief Financial Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
0
-100%
3,482
$180.12
$627,177.80
SELL
30 Aug 2021
Lebwohl David
EVP, Chief Medical Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
2,991
-44%
2,400
$158.04
$379,300.00
SELL
30 Aug 2021
Sepp-Lorenzino Laura
EVP, Chief Scientific Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
83,552
-53%
97,000
$154.83
$15,018,054.00
SELL
30 Aug 2021
Goddard Glenn
EVP, Chief Financial Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
0
-100%
30,000
$159.45
$4,783,537.50
SELL
30 Aug 2021
LEONARD JOHN M
President and CEO, Director, Officer
Intellia Therapeutics, Inc.
(NTLA)
719,305
-14%
121,372
$160.83
$19,520,418.00
SELL
23 Aug 2021
LEONARD JOHN M
President and CEO, Director, Officer
Intellia Therapeutics, Inc.
(NTLA)
727,570
-3%
27,139
$152.01
$4,125,416.00
SELL
19 Aug 2021
LEONARD JOHN M
President and CEO, Director, Officer
Intellia Therapeutics, Inc.
(NTLA)
732,261
-3%
22,682
$151.28
$3,431,398.00
SELL
9 Aug 2021
Lebwohl David
EVP, Chief Medical Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
791
-75%
2,400
$164.05
$393,720.00
SELL
5 Aug 2021
Goddard Glenn
EVP, Chief Financial Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
10,098
-66%
20,000
$151.05
$3,021,056.00
SELL
4 Aug 2021
Sepp-Lorenzino Laura
EVP, Chief Scientific Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
26,920
-49%
26,000
$138.24
$3,594,357.00
SELL
21 Jul 2021
Donald Sternoff Beyer Jr
Congressman (House)
Intellia Therapeutics, Inc.
(NTLA)
N/A
N/A
N/A
$1,001 - $15,000
SELL
28 Jun 2021
FORMELA JEAN FRANCOIS
Director
Intellia Therapeutics, Inc.
(NTLA)
537,357
-50%
553,376
$132.73
$73,448,870.00
SELL
11 Jun 2021
FORMELA JEAN FRANCOIS
Director
Intellia Therapeutics, Inc.
(NTLA)
717,862
-21%
201,725
$87.04
$17,558,774.00
SELL
29 Apr 2021
FORMELA JEAN FRANCOIS
Director
Intellia Therapeutics, Inc.
(NTLA)
765,101
-0%
4,513
$85.43
$385,545.60
SELL
26 Apr 2021
FORMELA JEAN FRANCOIS
Director
Intellia Therapeutics, Inc.
(NTLA)
799,354
-30%
342,962
$85.96
$29,482,340.00
SELL
5 Apr 2021
FORMELA JEAN FRANCOIS
Director
Intellia Therapeutics, Inc.
(NTLA)
1,112,576
-0%
800
$84.98
$67,984.00
SELL
5 Apr 2021
DORSA CAROLINE
Director
Intellia Therapeutics, Inc.
(NTLA)
10,896
-40%
7,500
$82.19
$616,404.94
SELL
1 Apr 2021
Rivera Jose E
EVP, General Counsel, Officer
Intellia Therapeutics, Inc.
(NTLA)
146,832
-25%
50,455
$82.46
$4,160,558.80
SELL
1 Apr 2021
LEONARD JOHN M
President and CEO, Director, Officer
Intellia Therapeutics, Inc.
(NTLA)
681,222
-5%
38,209
$83.64
$3,195,661.00
SELL
26 Feb 2021
FORMELA JEAN FRANCOIS
Director
Intellia Therapeutics, Inc.
(NTLA)
1,113,376
-31%
501,945
$60.29
$30,262,716.00
SELL
9 Feb 2021
Rivera Jose E
EVP, General Counsel, Officer
Intellia Therapeutics, Inc.
(NTLA)
117,920
-8%
11,489
$75.00
$861,675.00
SELL
5 Feb 2021
LEONARD JOHN M
President and CEO, Director, Officer
Intellia Therapeutics, Inc.
(NTLA)
660,536
-7%
50,985
$71.70
$3,655,410.50
SELL
1 Feb 2021
Rivera Jose E
EVP, General Counsel, Officer
Intellia Therapeutics, Inc.
(NTLA)
109,592
-33%
54,659
$64.00
$3,497,902.50
SELL
1 Feb 2021
LEONARD JOHN M
President and CEO, Director, Officer
Intellia Therapeutics, Inc.
(NTLA)
584,601
-23%
177,745
$67.26
$11,955,395.00
SELL
15 Jan 2021
Donald Sternoff Beyer Jr
Congressman (House)
Intellia Therapeutics, Inc.
(NTLA)
N/A
N/A
N/A
$1,001 - $15,000
SELL
31 Dec 2020
Rivera Jose E
EVP, General Counsel, Officer
Intellia Therapeutics, Inc.
(NTLA)
51,990
-3%
2,078
$55.86
$116,077.08
SELL
31 Dec 2020
LEONARD JOHN M
President and CEO, Director, Officer
Intellia Therapeutics, Inc.
(NTLA)
475,488
-1%
6,239
$55.86
$348,510.53
SELL
31 Dec 2020
SCHIERMEIER ANDREW
EVP, Chief Operating Officer, Officer
Intellia Therapeutics, Inc.
(NTLA)
16,656
-7%
1,377
$55.86
$76,919.22
SELL
17 Dec 2020
KARSEN PERRY A
Director
Intellia Therapeutics, Inc.
(NTLA)
71,786
-55%
88,764
$53.55
$4,753,680.00
SELL
1 Dec 2020
Rivera Jose E
EVP, General Counsel, Officer
Intellia Therapeutics, Inc.
(NTLA)
50,487
-6%
3,364
$38.21
$128,525.05
SELL
27 Nov 2020
LEONARD JOHN M
President and CEO, Director, Officer
Intellia Therapeutics, Inc.
(NTLA)
467,352
-6%
35,000
$38.57
$1,350,000.00
SELL
25 Nov 2020
LEONARD JOHN M
President and CEO, Director, Officer
Intellia Therapeutics, Inc.
(NTLA)
467,352
-9%
50,000
$36.00
$1,800,000.00
BUY
20 Nov 2020
Thomas R. Carper
Congressman (Senate)
Intellia Therapeutics, Inc.
(NTLA)
N/A
N/A
N/A
$1,001 - $15,000
BUY
18 Nov 2020
Donald Sternoff Beyer Jr
Congressman (House)
Intellia Therapeutics, Inc.
(NTLA)
N/A
N/A
N/A
$1,001 - $15,000
SELL
16 Nov 2020
Rivera Jose E
EVP, General Counsel, Officer
Intellia Therapeutics, Inc.
(NTLA)
47,072
-12%
6,653
$34.36
$228,568.44
SELL
16 Nov 2020
LEONARD JOHN M
President and CEO, Director, Officer
Intellia Therapeutics, Inc.
(NTLA)
467,352
-4%
20,000
$34.00
$680,000.00
SELL
4 Nov 2020
Rivera Jose E
EVP, General Counsel, Officer
Intellia Therapeutics, Inc.
(NTLA)
42,315
-7%
3,364
$28.00
$94,192.00
SELL
4 Nov 2020
LEONARD JOHN M
President and CEO, Director, Officer
Intellia Therapeutics, Inc.
(NTLA)
467,352
-9%
50,000
$26.00
$1,300,000.00
SELL
15 Oct 2020
Rivera Jose E
EVP, General Counsel, Officer
Intellia Therapeutics, Inc.
(NTLA)
40,835
-12%
5,615
$24.20
$135,883.02
SELL
7 Oct 2020
LEONARD JOHN M
President and CEO, Director, Officer
Intellia Therapeutics, Inc.
(NTLA)
467,352
-1%
5,000
$21.83
$109,150.00
SELL
15 Sep 2020
Rivera Jose E
EVP, General Counsel, Officer
Intellia Therapeutics, Inc.
(NTLA)
36,294
-13%
5,615
$21.04
$118,139.60
SELL
1 Sep 2020
LEONARD JOHN M.
President and CEO, Director, Officer
Intellia Therapeutics, Inc.
(NTLA)
467,352
-1%
5,000
$21.83
$109,150.00
SELL
26 Aug 2020
Donald Sternoff Beyer Jr
Congressman (House)
Intellia Therapeutics, Inc.
(NTLA)
N/A
N/A
N/A
$1,001 - $15,000
SELL
18 Aug 2020
Rivera Jose E
EVP, General Counsel, Officer
Intellia Therapeutics, Inc.
(NTLA)
31,909
-14%
5,615
$21.00
$117,915.00
SELL
6 Aug 2020
LEONARD JOHN M.
President and CEO, Director, Officer
Intellia Therapeutics, Inc.
(NTLA)
467,352
-1%
5,000
$21.83
$109,150.00
SELL
15 Jul 2020
Rivera Jose E
EVP, General Counsel, Officer
Intellia Therapeutics, Inc.
(NTLA)
27,524
-16%
5,615
$22.70
$127,460.51
BUY
10 Jul 2020
Donald Sternoff Beyer Jr
Congressman (House)
Intellia Therapeutics, Inc.
(NTLA)
N/A
N/A
N/A
$1,001 - $15,000
SELL
1 Jul 2020
LEONARD JOHN M.
President and CEO, Director, Officer
Intellia Therapeutics, Inc.
(NTLA)
467,352
-1%
5,000
$21.83
$109,150.00
SELL
16 Jun 2020
Rivera Jose E
EVP, General Counsel, Officer
Intellia Therapeutics, Inc.
(NTLA)
22,282
-20%
5,615
$21.00
$117,915.00
SELL
3 Jun 2020
LEONARD JOHN M.
President and CEO, Director, Officer
Intellia Therapeutics, Inc.
(NTLA)
467,352
-1%
5,000
$21.83
$109,150.00
SELL
26 May 2020
Rivera Jose E
EVP, General Counsel, Officer
Intellia Therapeutics, Inc.
(NTLA)
280,107
-1%
5,615
$21.21
$119,094.15
BUY
14 Jan 2020
Donald Sternoff Beyer Jr
Congressman (House)
Intellia Therapeutics, Inc.
(NTLA)
N/A
N/A
N/A
$1,001 - $15,000
BUY
9 Dec 2019
Donald Sternoff Beyer Jr
Congressman (House)
Intellia Therapeutics, Inc.
(NTLA)
N/A
N/A
N/A
$1,001 - $15,000
BUY
6 Mar 2019
SCHIERMEIER ANDREW
EVP, Dev and Corp Strategy, Officer
Intellia Therapeutics, Inc.
(NTLA)
3,250
+176%
7,500
$15.72
$117,875.00
SELL
25 Oct 2018
James M. Inhofe
Congressman (Senate)
Intellia Therapeutics, Inc.
(NTLA)
N/A
N/A
N/A
$15,001 - 50,000
SELL
16 Jul 2018
FORMELA JEAN FRANCOIS
Director
Intellia Therapeutics, Inc.
(NTLA)
1,402
-82%
6,686
$31.17
$208,397.28
SELL
19 Jun 2018
FORMELA JEAN FRANCOIS
Director
Intellia Therapeutics, Inc.
(NTLA)
1,400
-82%
6,686
$27.96
$186,908.23
SELL
16 May 2018
FORMELA JEAN FRANCOIS
Director
Intellia Therapeutics, Inc.
(NTLA)
0
-100%
6,686
$25.04
$167,389.36
SELL
14 May 2018
LEONARD JOHN M.
President and CEO, Director, Officer
Intellia Therapeutics, Inc.
(NTLA)
0
-100%
8,400
$24.00
$201,600.00
SELL
20 Mar 2018
FORMELA JEAN FRANCOIS
Director
Intellia Therapeutics, Inc.
(NTLA)
36,628
-51%
39,245
$23.87
$936,742.60
SELL
29 Jan 2018
Caribou Biosciences, Inc.
10% Owner
Intellia Therapeutics, Inc.
(NTLA)
3,994,355
-12%
550,645
$26.78
$14,746,273.00
SELL
12 Dec 2017
Novartis Institutes for BioMedical Research, Inc.
10% Owner
Intellia Therapeutics, Inc.
(NTLA)
4,129,903
-26%
1,523,000
$18.30
$27,870,898.00
SELL
6 Dec 2017
Bermingham Nessan
President & CEO, Director, Officer
Intellia Therapeutics, Inc.
(NTLA)
458,250
-42%
336,783
$20.78
$7,000,019.00
BUY
19 Oct 2017
James M. Inhofe
Congressman (Senate)
Intellia Therapeutics, Inc.
(NTLA)
N/A
N/A
N/A
$15,001 - 50,000
SELL
7 Jul 2017
Atlas Venture Fund IX, L.P.
10% Owner
Intellia Therapeutics, Inc.
(NTLA)
3,579,788
-4%
150,000
$16.24
$2,435,440.00
SELL
7 Jul 2017
FORMELA JEAN FRANCOIS
Director
Intellia Therapeutics, Inc.
(NTLA)
3,579,788
-4%
150,000
$16.24
$2,435,440.00
SELL
9 Mar 2017
Atlas Venture Associates IX, L.P.
10% Owner
Intellia Therapeutics, Inc.
(NTLA)
0
-100%
21,132
$13.91
$293,842.62
SELL
9 Mar 2017
FORMELA JEAN FRANCOIS
Director
Intellia Therapeutics, Inc.
(NTLA)
0
-100%
21,132
$13.91
$293,842.62
BUY
11 May 2016
Temasek Holdings (Private) Ltd
10% Owner
Intellia Therapeutics, Inc.
(NTLA)
790,527
+61%
300,000
$18.00
$5,400,000.00
BUY
11 May 2016
GORDON CARL L
Director
Intellia Therapeutics, Inc.
(NTLA)
2,603,646
+10%
250,000
$18.00
$4,500,000.00
BUY
11 May 2016
BAKER BROS. ADVISORS LP
Former 10% owner
Intellia Therapeutics, Inc.
(NTLA)
85,906
+175%
200,000
$18.00
$3,600,000.00
BUY
11 May 2016
ORBIMED ADVISORS LLC
Director
Intellia Therapeutics, Inc.
(NTLA)
2,603,646
+10%
250,000
$18.00
$4,500,000.00
BUY
11 May 2016
Novartis Institutes for BioMedical Research, Inc.
10% Owner
Intellia Therapeutics, Inc.
(NTLA)
5,573,658
+5%
277,777
$18.00
$4,999,986.00
Home